Carisma Therapeutics Ownership | Who Owns Carisma Therapeutics?


OverviewForecastRevenueFinancialsChart

Carisma Therapeutics Ownership Summary


Carisma Therapeutics is owned by 11.77% institutional investors, 30.93% insiders, and 57.30% retail investors.

CARM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCarisma Therapeutics11.77%30.93%57.30%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024382.70%4,888,967-6.07%117.50%1645.45%7-41.67%
Sep 30, 202437-24.49%5,205,020-14.78%125.80%11-60.71%12-7.69%
Jun 30, 202449-2.00%6,107,691-28.20%143.40%2855.56%13-31.58%
Mar 31, 202450-3.85%8,506,543-5.48%204.19%18-21.74%1946.15%
Dec 31, 202352-10.34%8,999,825-3.93%224.12%239.52%13-27.78%

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

CARM Ownership FAQ


Who Owns Carisma Therapeutics?

Carisma Therapeutics shareholders are primarily institutional investors at 11.77%, followed by 30.93% insiders and 57.30% retail investors. The average institutional ownership in Carisma Therapeutics's industry, Biotech Stocks , is 68.48%, which Carisma Therapeutics falls below.

Does Blackrock own Carisma Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Carisma Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools